Robotics- and AI-based hospital and home rehabilitation for children with spinal cord injury

ISRCTN ISRCTN19102055
DOI https://doi.org/10.1186/ISRCTN19102055
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number 2263
Sponsor Inrobics Social Robotics, S.L.
Funders Inrobics Social Robotics, S.L., Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades
Submission date
29/10/2025
Registration date
29/10/2025
Last edited
29/10/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
This study explores how assistive social robotics and artificial intelligence can enhance rehabilitation for children with spinal cord injury. The goal is to assess the usability, satisfaction, and effectiveness of the INROBICS platform - a robotic system designed to support physical therapy both in hospital and at home.

Who can participate?
Children aged 7–16 years with spinal cord injury below the C6 level, who are clinically stable and can sit independently, will be invited to participate. Participants must have parental consent.

What does the study involve?
Participants will be randomly assigned to one of two groups. The intervention group will complete 15 rehabilitation sessions using the INROBICS robot at the hospital and 15 sessions at home using the virtual version. The control group will receive 30 conventional therapy sessions. Each session includes warm-up, main exercise, and cool-down phases. Assessments will be performed before, during, and after treatment, and again three months later.

What are the possible benefits and risks of participating?
The Inrobics Rehab system may improve rehabilitation engagement, motor recovery, and emotional wellbeing. Risks are minimal and similar to standard therapy; sessions are supervised by rehabilitation professionals.

Where is the study run from?
The study is conducted at the Hospital Nacional de Parapléjicos (Toledo, Spain) in collaboration with Inrobics Social Robotics, S.L.

When is the study starting and how long is it expected to run for?
March 2024 to February 2027

Who is funding the study?
The study is funded by the Ministry of Science, Innovation and Universities (Spain), under the Public–Private Collaboration Programme 2023

Who is the main contact?
Dr Ana de los Reyes Guzmán, adlos@sescam.jccm.es

Contact information

Mrs Ana De los Reyes
Scientific, Principal investigator

FINCA DE, Carr. de la Peraleda S/N
Toledo
45004
Spain

Phone +34 (0)925247700
Email adlos@sescam.jccm.es
Mrs Fuensanta García
Public

Av. Gregorio Peces Barba 1
Madrid
28919
Spain

ORCiD logoORCID ID 0009-0003-5104-0491
Phone +34 (0)630423231
Email fgarcia@inrobics.com

Study information

Primary study designInterventional
Study designClinical, analytical, experimental, prospective, randomized controlled study
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleHospital and home rehabilitation based on social assistive robotics and artificial intelligence for paediatric patients
Study objectivesThe general objective of the study is to analyse the user experience, usability and effectiveness of the Inrobics Rehab platform based on Social Assistance Robotics and Artificial Intelligence.
Ethics approval(s)

Approved 24/09/2025, Ethics Committee for Clinical Research with Medicines at the Toledo University Hospital Complex (Av. del Río Guadiana, Toledo, 45007, Spain; +34 (0)925269200 extension: 48557; ceic-chto-secretario@sescam.jccm.es), ref: 2263

Health condition(s) or problem(s) studiedPaediatric school patients aged between 7 and 16 years with subacute or chronic spinal cord injury
InterventionParticipants will be randomly assigned to either the intervention group or the control group
using a simple randomisation technique. A computer-generated list of random numbers will
determine treatment allocation, which will be concealed in sequentially numbered, sealed
envelopes. Each participant receives the envelope in order of enrolment, revealing assignment
to either the INROBICS intervention group or the control group.

1. Intervention group: each participant will complete 15 sessions with the INROBICS Clinic platform and 15 with INROBICS Virtual spread over 4 weeks.
2. Control group: each participant will receive 30 experimental sessions of conventional therapy over 4 weeks.
Intervention typeDevice
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Inrobics Rehab
Primary outcome measure(s)

Assessments are conducted at four timepoints: T0 (baseline evaluation), T1 (post-clinical intervention), T2 (post-virtual intervention), and T3 (3-month follow-up)

Efficacy Measures:
1. PENN Spasm Frequency Scale: Assesses the frequency and severity of muscle spasms, providing a quantitative evaluation of spasticity (T0)
2. Electronic Spinal Cord Independence Measure (e-SCIM-III): Evaluates functional independence in patients with spinal cord injury (SCI) (T0, T1, T2, T3)

Emotional State:
1. Children’s Depression Inventory (CDI): Administered to participants under 16 years of age (T0, T1, T2, T3)
2. State-Trait Anxiety Inventory for Children (STAIC): Administered to participants aged 9–15 years (T0, T1, T2, T3)

Perceived Health and Mental Workload:
1. EQoL-5D-Y5L: Assesses perceived quality of life. (T0, T1, T2, T3)
2. Pain (VAS): Pain intensity is measured using the Visual Analogue Scale with emoticons suitable for children and adolescents (T0, T1, T2, T3)
3. NASA-TLX: Evaluates perceived mental workload and fatigue associated with the training tasks (T1, T2)

Cognitive Scales:
1. Digit Span (WISC-V subtest): Evaluates attention and working memory in participants under 16 years (T0, T1, T2, T3)
2. Face Perception Test: Assesses perceptual and attentional skills in participants under 16 years (T0, T1, T2, T3)
3. Executive Function Inventory (EFI): Completed by parents for children over 6 years to assess executive functioning in daily life (T0, T1, T2, T3)

Functional Scales:
1. Edinburgh Handedness Inventory: Determines hand dominance in participants over 3 years (T0)
2. Box and Block Test: Assesses gross manual dexterity in participants over 6 years (T0, T1, T2, T3)
3. Jebsen–Taylor Hand Function Test: Evaluates hand function and coordination in participants over 6 years (T0, T1, T2, T3)

Motor Assessment:
1. Upper Limb Kinematic Evaluation: Quantifies movement precision and quality during activities of daily living (ADLs) using the assistive social robotics system (see Annex 3) (T0, T2, T3)

Key secondary outcome measure(s)

Assessments are conducted at four timepoints: T0 (baseline evaluation), T1 (post-clinical intervention), T2 (post-virtual intervention), and T3 (3-month follow-up)

Usability Measures:
1. QUEST 2.0 (Quebec User Evaluation of Satisfaction with Assistive Technology): Assesses user satisfaction with the assistive device (T1, T2)
2. IPAQ Questionnaire: Measures time spent performing different physical activities in children and adolescents (T0, T1, T2, T3)
3. Hopkins Scale: Evaluates engagement in the training program for both adult and paediatric participants (T1, T2)

Device-Recorded Parameters:
1. All kinematic and physiological parameters are recorded using the Inrobics Rehab system and R software (version 4.3.1 for Ubuntu)
2. Range of Motion: Goniometric data capturing joint mobility (T1, T2)
3. Accuracy Rate: Quantifies successful task completion (T1, T2)
4. Trunk and Neck Deviation: Monitors postural deviations during training (T1, T2)
5. % Heart Rate Reserve (%HRR): Determines exercise intensity during sessions (T1, T2)
6. Motor Precision: Assesses the accuracy of reproduced target postures (T1, T2)
7. Reaction Time: Measures the latency between stimulus onset and movement initiation (T1, T2)
8. Engagement: Indicates the level of active participation throughout the task (T1, T2)
9. Performance by Activity Type: Evaluates execution across different motor games (e.g., dance, don’t stop, symbolic), combining metrics such as reaction time, memory rate, accuracy rate, learning rate, and execution speed (T1, T2)

User Satisfaction:
1. Self-Assessment Manikin (SAM): A pictorial, non-verbal scale assessing pleasure, arousal, and dominance associated with affective responses to stimuli (T1, T2)

Completion date28/02/2027

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit7 Years
Upper age limit16 Years
SexAll
Target sample size at registration52
Key inclusion criteria1. Aged between 7 and 16 years old
2. Clinically stable
3. Diagnosis of spinal cord injury below C6 in cases of AIS (ASIA Impairment Scale) severity A or B, or any level of incomplete spinal cord injury that allows reach with the upper limbs
4. Independent sitting (including technical aids such as belts, wedges, trunk supports, etc)
5. Parents, guardians or family members must have signed the corresponding informed consent form
Key exclusion criteria1. Unstable orthopaedic injuries such as unconsolidated fractures or unstable osteosynthesis systems in the upper limbs
2. Suffering from severe pain, joint stiffness and/or severe spasticity in the upper limbs
3. Severe bronchopneumopathy and/or heart disease requiring monitoring during exercise or a history of abnormal response to physical exertion prior to spinal cord injury
4. Severe visual impairments, cognitive impairment and/or incapacitating psychiatric illness
Date of first enrolment01/11/2025
Date of final enrolment02/02/2027

Locations

Countries of recruitment

  • Spain

Study participating centre

Hospital Nacional de Parapléjicos
FINCA DE, Carr. de la Peraleda S/N
Toledo
45004
Spain

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
IPD sharing planData sharing plans for the current study are unknown and will be available at a later date

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Protocol file 29/10/2025 No No
Study website Study website 11/11/2025 11/11/2025 No Yes

Additional files

48307_PROTOCOL.pdf
Protocol file

Editorial Notes

29/10/2025: Study's existence confirmed by the Ethics Committee for Clinical Research with Medicines at the Toledo University Hospital Complex.